2023-01-25 23:00:00

Global Gene Therapy Market Report 2022: Featuring Novartis, Pfizer, MeiraGTx, San Rocco Therapeutics & More

Logo PR Newswire
PR Newswire

DUBLIN, Jan. 25, 2023 /PRNewswire/ -- The "Global Gene Therapy Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The global gene therapy market is expected to grow at a CAGR of 18.39% over the forecast period to reach US$11.769 billion by 2027 from US$3.611 billion in 2020.

Gene therapy refers to a medical process that modifies or teat an individual's underlying genetic problem thereby preventing disease. Such therapy has high applicability in the treatment of major diseases such as cancer, diabetes, heart disease, and HIV among others as its ability to replace unhealthy genes with new ones provides the body with the ability to fight such diseases.

Unhealthy food consumption, lifestyle factors, and the rising prevalence of obesity, coupled with the rapid increase in the population and economic downturn have increased the prevalence of chronic and infectious diseases such as cancer, diabetes, HIV, and heart disease.

For instance, according to the World Health Organization, in 2020, the number of deaths that occurred due to cancer globally stood at 10 million with which death count by breast cancer stood at 2.26 million followed by lung cancer at 2.21 million. Furthermore, according to US Government's HIV.gov data, in 2021, 1.2 million people in the United States were diagnosed with HIV.

Moreover, according to the 2020 Health and Glance report by European Commission, in 2019, the total number of people diagnosed with diabetes stood at 32.3 million which showed significant growth of 92.2% from the cases reported in 2000. Owing to the rapidly growing prevalence of such major diseases, the demand for gene therapy products is also projected to increase, thereby boosting the global gene therapy market growth during the forecast period.

Based on vector type, the global gene therapy market is segmented into viral and non-viral vectors. The non-viral vector is expected to grow at a relatively higher rate during the forecast period of the global gene therapy market. Non-viral vector has low cost, is easy to produce, has better cell or tissue targeting, and provides biosafety advantages over viral vector which makes the non-viral vector much safer to be used in gene delivery.

Owing to its rich performance benefits, the non-viral vector has a higher preference over the viral vector, and with the increase in the number of major communicable and non-communicable diseases such as cancer, diabetes, and AIDS, the demand for non-viral vectors for gene therapy is also expected to increase, thereby improving its segment as well as the overall market growth during the forecast period.

The growing establishment of gene therapy manufacturing plants by major companies is boosting the global gene therapy market growth. Various companies realizing the importance of gene therapy and its effectiveness against a wide range of deadly diseases are actively investing in innovations and plant establishments to increase their production of gene therapy products.

For instance, in June 2022, REGEXBIO announced the establishment of its new gene therapy manufacturing center in Rockville, Md where the company will boost the manufacturing of its adeno-associated virus vectors using the company's NAV technology. Furthermore, in December 2021, Pfizer opened its new state-of-the-art gene manufacturing facility in Durham, NC, where the company will boost the production of its multiple gene therapy medicine. Such manufacturing plant establishments will increase the demand and scope of usage of gene therapy in the future, thereby boosting the market growth of the global gene therapy market during the forecast period.

Recent developments:

  • In October 2022, Elli Lily and Company signed an agreement for the acquisition of Akouos for a sum of US$610 million. The acquisition will enable Elli Lily to add major gene therapy products of Akouos such as AK-OTOF which is used for treating hearing loss caused due to otoferlin gene mutations.
  • In August 2022, Cytiva collaborated with Forecyte Bio to accelerate the manufacturing and development of the gene therapy industry in the United State and China markets. The company's collaboration will increase the patient's access to gene therapy.

Market Segmentation:
By Therapy Type

  • Ex Vivo
  • In Vivo
  • In Situ

By Vector Type

  • Viral
  • Non-Viral

By Technique Type

  • Gene Augmentation
  • Gene Inhibition
  • Specific Cell Kill

By Disease Type

  • Cancer
  • Heart Disease
  • Diabetes
  • HIV
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • Israel
  • United Arab Emirates
  • Others
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Indonesia
  • Thailand
  • Taiwan
  • Others

Key Topics Covered:

1. INTRODUCTION

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

5. GLOBAL GENE THERAPY MARKET BY THERAPY TYPE

6. GLOBAL GENE THERAPY MARKET BY VECTOR TYPE

7. GLOBAL GENE THERAPY MARKET BY TECHNIQUE TYPE

8. GLOBAL GENE THERAPY MARKET BY DISEASE TYPE

9. GLOBAL GENE THERAPY MARKET BY GEOGRAPHY

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

11. COMPANY PROFILES

Companies Mentioned

  • Novartis
  • Pfizer Inc
  • MeiraGTx Limited
  • San Rocco Therapeutics
  • American Gene Technologies
  • IVERIC bio, Inc
  • Lysogene
  • AVROBIO Inc
  • Adverum Biotechnologies Inc
  • Spark Therapeutics, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/jur88w-gene?w=5

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

Cision View original content:https://www.prnewswire.com/news-releases/global-gene-therapy-market-report-2022-featuring-novartis-pfizer-meiragtx-san-rocco-therapeutics--more-301730896.html

SOURCE Research and Markets

Logo PR Newswire
HealthPress Release2023-01-25 18:50:00
DUBLIN, Jan. 25, 2023 /PRNewswire/ -- The "CRISPR Technology: Global Markets" report has been added to ResearchAndMarkets.com's offering. A $9.2 Billion...

Logo PR Newswire
DUBLIN, Jan. 25, 2023 /PRNewswire/ -- The "Automated and Closed Cell Therapy Processing Systems Market by Workflow, Type, Scale, and by Region - Global...

Logo PR Newswire
HealthPress Release2023-01-25 15:40:00
DUBLIN, Jan. 25, 2023 /PRNewswire/ -- The "Global Consumer Genomics Market (2022-2027) by Product and Service, Application, and Geography, Competitive...

Logo EIN Presswire
Nucleic Acid Based Gene Therapy Global Market Report 2023 – Market Size, Trends, And Global Forecast 2023-2032 The Business Research Company's Nucleic Acid...

Logo PR Newswire
HealthPress Release2023-01-25 20:30:00
DUBLIN, Jan. 25, 2023 /PRNewswire/ -- The "Psoriasis Therapeutics Market By Drug Class, By Type, By Route of Administration: Global Opportunity Analysis and...

Logo PR Newswire
HealthPress Release2023-01-25 15:50:00
DUBLIN, Jan. 25, 2023 /PRNewswire/ -- The "Global Prenatal and New-born Genetic Testing Market (2022-2027) by Type, Technology, Application, and Geography,...

Logo PR Newswire
HealthPress Release2023-01-25 00:00:00
DUBLIN, Jan. 24, 2023 /PRNewswire/ -- The "Global Photoimmunotherapy Market by Therapeutic Area, End-user, and Region: Competition Forecast and Opportunities...

Logo PR Newswire
DUBLIN, Jan. 25, 2023 /PRNewswire/ -- The "RegTech Global Market Opportunities And Strategies To 2031" report has been added to ResearchAndMarkets.com's...

Logo PR Newswire
HealthPress Release2023-01-25 15:00:00
CHICAGO, Jan. 25, 2023 /PRNewswire/ -- Biologics Safety Testing Market is projected to reach USD 6.8 billion by 2027 from USD 3.6 billion in 2022, at a CAGR...

Logo PR Newswire
DUBLIN, Jan. 23, 2023 /PRNewswire/ -- The "Cancer Gene Therapy Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's...

Logo PR Newswire
HealthPress Release2023-01-25 10:40:00
DUBLIN, Jan. 25, 2023 /PRNewswire/ -- The "Laboratory Developed Tests Market Size, Share & Trends Analysis Report By Technology (Immunoassay, Molecular...

Logo PR Newswire
HealthPress Release2023-01-25 22:40:00
DUBLIN, Jan. 25, 2023 /PRNewswire/ -- The "Pharmaceutical API Manufacturing Global Market Opportunities And Strategies To 2031" report has been added to...

Logo GlobeNewswire
EconomyPress Release2023-01-24 14:30:00
Burlingame, Jan. 24, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, Global Cancer Therapy Market is estimated to be valued at US$ 1 84. 8 b...

Logo PR Newswire
HealthPress Release2023-01-25 11:50:00
DUBLIN, Jan. 25, 2023 /PRNewswire/ -- The "Orthopedic Implants Market, Global Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity...

Logo PR Newswire
HealthPress Release2023-01-25 16:20:00
DUBLIN, Jan. 25, 2023 /PRNewswire/ -- The "North America Large Molecule Drug Substance CDMO Market Size, Share & Industry Trends Analysis Report By...

Logo PR Newswire
HealthPress Release2023-01-25 20:40:00
DUBLIN, Jan. 25, 2023 /PRNewswire/ -- The "Alzheimer's Drugs Market, Global Forecast 2023-2027, Industry Trends, Growth, Insight, Impact of Inflation,...

Logo PR Newswire
HealthPress Release2023-01-25 14:10:00
DUBLIN, Jan. 25, 2023 /PRNewswire/ -- The "Infant Phototherapy Market, Global Forecast 2023-2027, Industry Trends, Growth, Impact of Inflation, Opportunity...

Logo PR Newswire
DUBLIN, Jan. 25, 2023 /PRNewswire/ -- The "Global Food Allergy Diagnostics & Therapeutics Market (2022-2027) by Product Type, Source, End-user, and...

Logo PR Newswire
HealthPress Release2023-01-25 15:30:00
DUBLIN, Jan. 25, 2023 /PRNewswire/ -- The "Global Mycoplasma Diagnostics Market (2022-2027) by Type, Technique, Application, End-user, and Geography,...

Logo Benzinga
Business / FinanceBy Pr Newswire2023-01-25 15:30:00
The growth of the Huntington's disease market is expected to be mainly driven by less competitive scenarios, entry of innovative emerging therapies, rising...